I
Impilo
Cutting-edge remote patient monitoring devices for enhanced patient care and outcomes
About Impilo
Impilo is at the forefront of transforming healthcare delivery through innovative remote patient monitoring solutions. The company develops and manufactures advanced medical devices that enable healthcare providers to monitor patients' vital signs and health metrics in real-time, outside of traditional clinical settings. By leveraging Internet of Things (IoT) technology and connected devices, Impilo's solutions allow for continuous data collection and analysis, providing healthcare professionals with valuable insights into patient health trends and potential issues. This proactive approach to patient care can lead to earlier interventions, reduced hospital readmissions, and improved overall health outcomes. Impilo's platform combines hardware devices with sophisticated software, offering a comprehensive solution for healthcare institutions. The company's focus on data analytics and integration with existing healthcare systems positions it as a valuable partner in the growing field of digital health and telemedicine. As healthcare continues to evolve towards more personalized and remote care models, Impilo is well-positioned to play a significant role in shaping the future of patient monitoring and care management.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2020
- Headquarters
- Philadelphia, United States
- Employees
- 57
- Open positions
- None listed
- Dealroom signal
- 65.4/100
- Industry
- Health, Enterprise Software
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Health and Wellness, Medical & Healthcare, Remote Monitoring, Patient Care, Healthcare Technologies, remote health monitoring
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Nov 2024 | $12M | $46M | One Way Ventures · Construct Capital · 2048 Ventures | ↗ |
| SEEDEquity / VC | Feb 2024 | $0 | — | 2048 Ventures | — |
Growth signals
Latest recorded traffic for Impilo is 6.9K monthly website visits, down 15.9% over the last three months. Impilo's team declined 13.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
2048 Ventures
Looking Glass
TA Ventures
Series A2 investors entered at this stage
Construct Capital
One Way Ventures
Other known investors5 additional known investors
C2 Ventures
Coalition Operators
GC1 Ventures
ICLUB Global
Rough Draft Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Impilo on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Impilo’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.